Edition:
India

Atyr Pharma Announces Reverse Stock Split To Regain Nasdaq Compliance


Saturday, 29 Jun 2019 

June 28 (Reuters) - aTyr Pharma Inc ::ATYR PHARMA ANNOUNCES REVERSE STOCK SPLIT TO REGAIN NASDAQ COMPLIANCE.ANNOUNCES 1 FOR 14 REVERSE STOCK SPLIT.PAR VALUE OF COMPANY'S COMMON STOCK WILL REMAIN UNCHANGED AT $0.001 PER SHARE AFTER REVERSE STOCK SPLIT.ONE-FOR-14 REVERSE STOCK SPLIT IS SCHEDULED TO BECOME EFFECTIVE AFTER TRADING CLOSES ON JUNE 28, 2019. 

Company Quote

3.67
 --
13 Sep 2019